Brain Cancer

Danish Study Suggests Contraceptive Use Increases Risk of Brain Cancer (02-3-2015)

The results of a recently published clinical study suggest that taking the birth control pill for at least five years may double the risk of developing a glioblastoma multiforme (GBM), a rare but often fatal from of brain cancer. Glioblastoma multiforme... Continue Reading

DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial (09-19-2014)

DNAtrix, Inc., experts in oncolytic virus development, today announced that the first patient was treated with the company’s lead product, DNX-2401, a replication competent adenovirus plus gamma interferon in a randomized, multicenter, open-label... Continue Reading

Chemotherapy Following Radiation Improves Outcomes in Low Grade Glioblastoma (06-24-2014)

According to results recently presented at the 2014 annual meeting of the American Society of Clinical Onoclogy, patients with low-grade glioblastom multiforme (GBM) benefited from chemotherapy following radiation therapy compared to radiation therapy... Continue Reading

Follow-Up Study Shows ICT-107 Vaccine Fails to Extend Survival in GBM (01-27-2014)

Despite promising results in a phase I trial, the vaccine ICT-107 failed to significantly prolong overall survival in patients with glioblastoma multiforme in a follow-up phase II trial.[1] Glioblastoma multiforme (GBM) is an aggressive type of type of... Continue Reading

Novel Vaccine Prolongs Survival in Glioblastoma Multiforme (12-20-2013)

Eight of 16 patients with glioblastoma multiforme who participated in a vaccine study survived longer than fiver years after diagnosis, according to the results of a study presented at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology. Glioblastoma... Continue Reading

No Added Toxicity with Avastin in Glioblastoma (10-9-2013)

The addition of Avastin® (bevacizumab) to standard chemoradiation significantly slowed the progression of glioblastoma without added toxicity, according to the results of a study presented at the annual meeting of the American Society of Radiation Oncology. Glioblastoma... Continue Reading

Antiviral Drug May Extend Survival in Glioblastoma (09-25-2013)

The common antiviral drug Valcyte (valganciclovir) may extend survival in glioblastoma, according to the results of a study published in the New England Journal of Medicine. Glioblastoma is one of the most common and fatal types of primary brain cancer.... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (09-16-2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive... Continue Reading

Avastin Doesn’t Improve Survival in Newly Diagnosed Glioblastoma (06-7-2013)

In a Phase III clinical trial among patients with newly diagnosed glioblastoma, the addition of Avastin® (bevacizumab) to standard chemoradiation increased side effects and did not improve overall survival. These results were presented at the 2013 Annual... Continue Reading

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors (05-22-2013)

Study Seeking to Enroll 222 Patients; Largest Vaccine Trial Ever Funded by NCI in Brain Tumors and the Largest Cancer Vaccine Study Ever Conducted in Combination With Avastin LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) — Agenus Inc. (Nasdaq:AGEN)... Continue Reading

« Previous PageNext Page »